Ireland
--:--IST
Priya Life Science Medicines register
Registers› Irish medicines ›Binocrit 10 000 IU/1 mL solution for injection in a pre-filled syringe
Medicines register · Ireland

Binocrit 10 000 IU/1 mL solution for injection in a pre-filled syringe

Authorisation EU/1/07/410/15-16 · Sandoz GmbH

Source: Health Products Regulatory Authority (HPRA), open dataset, CC BY 4.0. HPRA list dated 19 Nov 2026
Licence holder
Sandoz GmbH (all products →)
Active substance
Recombinant human erythropoietin alfa
Dosage form
Solution for injection in pre-filled syringe
Routes of administration
Intravenous use, Subcutaneous use
ATC codes
B03XA, B03XA01
Prescription status
Product subject to prescription which may not be renewed (A)
Supply
Supply through pharmacies only
Legal basis
Similar biological application (Article 10(4) of Directive No 2001/83/EC)

Recombinant human erythropoietin alfa: supply and approvals

24 authorised products on the HPRA list contain Recombinant human erythropoietin alfa. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.

EU shortage (EMA)
No entry in the EMA shortage catalogue (checked 19 Nov 2026)
US shortage (FDA)
No entry in the FDA drug shortage list (checked 19 Nov 2026)
Germany (BfArM)
No entry in the BfArM supply notices (checked 19 Nov 2026)

Registers: EU shortages · US shortages · German shortages · EMA approvals

About this licence

Centralised EU authorisation. This product holds an EU-wide marketing authorisation granted by the European Commission after assessment by the European Medicines Agency, valid in every EU country. Its EU product number is 410. The HPRA list does not say whether it is on sale.

Open the European Commission’s Union Register record →

Other medicines with Recombinant human erythropoietin alfa in Ireland

23 other products on the HPRA list contain Recombinant human erythropoietin alfa, from 3 licence holders; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.

MedicineLicence holderLicenceStatus
Abseamed 1 000 IU/0.5 mL solution for injection in a pre-filled syringeMedice Arzneimittel Putter GmbH & Co. K.GCentralised EU authorisationNot stated
Abseamed 10 000 IU/1 mL solution for injection in a pre-filled syringeMedice Arzneimittel Putter GmbH & Co. K.GCentralised EU authorisationNot stated
Abseamed 2 000 IU/1 mL solution for injection in a pre-filled syringeMedice Arzneimittel Putter GmbH & Co. K.GCentralised EU authorisationNot stated
Abseamed 3 000 IU/0.3 mL solution for injection in a pre-filled syringeMedice Arzneimittel Putter GmbH & Co. K.GCentralised EU authorisationNot stated
Abseamed 4 000 IU/0.4 mL solution for injection in a pre-filled syringeMedice Arzneimittel Putter GmbH & Co. K.GCentralised EU authorisationNot stated
Abseamed 5 000 IU/0.5 mL solution for injection in a pre-filled syringeMedice Arzneimittel Putter GmbH & Co. K.GCentralised EU authorisationNot stated
Abseamed 6 000 IU/0.6 mL solution for injection in a pre-filled syringeMedice Arzneimittel Putter GmbH & Co. K.GCentralised EU authorisationNot stated
Abseamed 8 000 IU/0.8 mL solution for injection in a pre-filled syringeMedice Arzneimittel Putter GmbH & Co. K.GCentralised EU authorisationNot stated
Binocrit 1 000 IU/0.5 mL solution for injection in a pre-filled syringeSandoz GmbHCentralised EU authorisationNot stated
Binocrit 2 000 IU/1 mL solution for injection in a pre-filled syringeSandoz GmbHCentralised EU authorisationNot stated
Binocrit 3 000 IU/0.3 mL solution for injection in a pre-filled syringeSandoz GmbHCentralised EU authorisationNot stated
Binocrit 4 000 IU/0.4 mL solution for injection in a pre-filled syringeSandoz GmbHCentralised EU authorisationNot stated

All 24 products with Recombinant human erythropoietin alfa →

Other substances in ATC group B03XA

The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 6 other active substances share the group B03XA with this product:

Xm01 drug substance epoetin theta (16) · Epoetin alfa (9) · Epoetin zeta (6) · Roxadustat (5) · Darbepoetin alfa (4) · Vadadustat (3)

Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.

The licence holder

Sandoz GmbH holds 67 products on the HPRA list, with 17 different active substances; 0 of the products are marked as marketed.

Shortages and approvals, every Friday

One email a week with ongoing EU and US medicine shortages, new EMA and FDA approvals and clinical trials recruiting in Ireland.

Free. Unsubscribe from any email with one click. See our privacy policy.

This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.

How this page is built

The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.

This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 20 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.